• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 12, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

PNNL waives fee to test-drive portfolio of intellectual property

Bioengineer by Bioengineer
June 11, 2020
in Science News
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Special exploratory license agreement designed to spur economic recovery

IMAGE

Credit: Andrea Starr | Pacific Northwest National Laboratory

RICHLAND, Wash. — As businesses of all sizes weather today’s tough economy, the U.S. Department of Energy’s Pacific Northwest National Laboratory is offering its entire portfolio of patented technologies on a research trial basis–at no cost–to spur economic development and ultimately create new jobs.

Dozens of technologies could be deployed across U.S. markets spanning everything from analytical instruments, human health and agriculture to advanced manufacturing, cybersecurity and renewable energy. Through the six-month trial period, businesses can try out PNNL’s technologies.

“Our goal is to quickly and inexpensively put these innovations into the hands of companies, entrepreneurs and investors where they can be productized and deployed,” PNNL Director of Technology Deployment and Outreach Lee Cheatham explained.

Some of PNNL’s intellectual property could be applied to help with the COVID-19 pandemic. For example, one of the most recent additions to the portfolio is a coating called ElastiDry. This inexpensive and stretchable superhydrophobic material could be included during the manufacture of latex gloves–or other protective clothing–to make personal protective equipment impenetrable to deadly viruses.

No-cost trial period for on-site testing

From now through December 31, 2020, the standard $1,000 fee will be waived for organizations and entrepreneurs interested in signing a nonexclusive exploratory license agreement, which means more than one organization can hold a license for the same technology. The agreement allows entrepreneurs and organizations to test a technology within their own product lines before entering into a formal licensing agreement.

Details of the special exploratory license agreement include:

  • Use of intellectual property with the option to negotiate a commercial license for the patent; the agreement holds the licensee’s access to intellectual property during the exploratory period.
  • A simplified, two-page form.
  • Simplified terms.
  • Rapid execution–PNNL expects to turn around licenses in less than two weeks.

“As a Department of Energy national laboratory, one of our primary missions is to transfer technologies developed through federal funding to the marketplace, where they can make a real difference,” Cheatham said. “As our nation struggles with how to jump-start our economy, now more than ever, we want to speed the process.”

###

To learn more, visit PNNL’s Exploratory License page.

Media Contact
Tom Rickey
[email protected]

Original Source

https://www.pnnl.gov/news-media/pnnl-waives-fee-test-drive-portfolio-intellectual-property

Tags: Business/EconomicsIntellectual PropertyLicenses/PatentsTechnology Transfer
Share12Tweet8Share2ShareShareShare2

Related Posts

Lesser Omental Panniculitis: An Acute Abdomen Case

November 12, 2025
Thyroid Peroxidase Variants as Subclinical Hypothyroidism Markers

Thyroid Peroxidase Variants as Subclinical Hypothyroidism Markers

November 12, 2025

Innovative Methods for Extracting Feather Keratin

November 12, 2025

MRI Predicts Biologic Therapy Response in Crohn’s Disease

November 12, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    316 shares
    Share 126 Tweet 79
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    208 shares
    Share 83 Tweet 52
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    140 shares
    Share 56 Tweet 35
  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1305 shares
    Share 521 Tweet 326

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Lesser Omental Panniculitis: An Acute Abdomen Case

Thyroid Peroxidase Variants as Subclinical Hypothyroidism Markers

Innovative Methods for Extracting Feather Keratin

iv>

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.